Dragony Fu explains the future of mRNA

“If we are currently witnessing mRNA vaccine 1.0 for COVID-19, then 2.0 will address two further categories of disease,” says Dragony Fu, an associate professor of biology. “One is pathogens, like SARS, but you can apply this technology to other foreign invaders such as HIV. Already before COVID, companies were in development making mRNA vaccines against HIV. The other category is autoimmune diseases,” he says. “That is intriguing because it’s verging beyond the very strict definition of a vaccine.”